USPTO serial 79203264
LCA PHARMACEUTICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 13, 2018
- Examiner
- TWOHIG, SHANNON MARIE
- Law office
- TMO LAW OFFICE 121
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LCA PHARMACEUTICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
FR
Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
FR
Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
FR
Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist Sughrue Mion, PLLC2100 Pennsylvania Avenue, N.W.Suite 800Washington, DC 20037Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, preparations for the treatment of osteoarthritis and other joint diseases; preparations for the treatment of pain and joint diseases, particularly osteoarthritis; injectable preparations for use in rheumatology, presented in the form of pre-filled disposable sterile syringes; preparations for dermatological use for filling in face wrinkles; pharmaceutical preparations for dermatological use; injectable preparations for dermatological use presented in the form of sterile pre-filled disposable syringes; Sterile, isotonic and preservative-free single doses for symptomatic treatments of eye irritations and for nose and eye care | SECTION 71 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments, namely, sterile single use instrumentation for cataract surgery; Medical devices for intracorporal injection, namely, lenses in the nature of intraocular prostheses for surgical implantation packed in an injector; medical devices for intracorporeal injection; medical devices for intracorporeal injection consisting of a disposable sterile syringe; artificial implants, namely introcular implants; sterile intraocular implants of artificial material and medical devices for use in cataract surgery | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research services; medical research services; scientific data analysis services; chemical analyses; chemical research; medical data analysis services; scientific research services for medical purposes, particularly design and development of implantable medical devices for use in ophthalmology, rheumatology and dermatology | SECTION 71 - CANCELLED | — |
| 044 | Medical services; medical assistance; health counseling services; pharmacy advice, namely, medical advice related to pharmaceuticals; health care for human beings; advisory services and medical services in the field of rheumatology and dermatology; hygiene and beauty care; all the aforementioned services not in the field of ophthalmology | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
- Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
- Other trademarks owned by LABORATOIRE DE CONTACTOLOGIE APPLIQUEE - LCA,
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LCA PHARMACEUTICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 24, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 2, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 2, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 27, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 27, 2024 | C71T | CANCELLED SECTION 71 | — |
| Mar 13, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 24, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 20, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 20, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 13, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 13, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 22, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 6, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 14, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 21, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 9, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 21, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 21, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 21, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 21, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |